Evidence map›Paper›PMID 41053365›Full record

ArticleCommunications biology2025

The acetyltransferase CysE modulates virulence and drug resistance of Mycobacterium tuberculosis by interfering with oxidative stress responses.

Lan-Yue Zhang, Han Yin, Ying-Chao Wang, Mei-Yi Yan, Chun-Liang Wang, Xue-Tian Shang, Wei-Yi Liu, Zi-Hui Li, Hong-Yan Jia, Zong-De Zhang and 3 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Serine Acetyltransferase fromInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lan-Yue Zhang *Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-8267-2059
Han Yin *NHC Key Laboratory of Systems Biology of Pathogens, State Key Laboratory of Respiratory Health and Multimorbidity, National Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ying-Chao Wang *Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Mei-Yi YanNHC Key Laboratory of Systems Biology of Pathogens, State Key Laboratory of Respiratory Health and Multimorbidity, National Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chun-Liang WangNHC Key Laboratory of Systems Biology of Pathogens, State Key Laboratory of Respiratory Health and Multimorbidity, National Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue-Tian ShangBeijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Wei-Yi LiuBeijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Zi-Hui LiBeijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Hong-Yan JiaBeijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Zong-De ZhangBeijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Chuan-Zhi ZhuBeijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China. chuanzhizhu@gmail.com.
Li-Ping PanBeijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China. panliping2006@163.com.ORCID http://orcid.org/0000-0001-6172-3630
Yi-Cheng SunNHC Key Laboratory of Systems Biology of Pathogens, State Key Laboratory of Respiratory Health and Multimorbidity, National Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. sunyc@ipbcams.ac.cn.ORCID http://orcid.org/0000-0002-5790-7071

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82402641
6 · The paper itself

Abstract

Acetyltransferases play a crucial role in biological processes by modifying a variety of substrates. However, their roles in the virulence of Mycobacterium tuberculosis (M. tb) are poorly understood. To systematically investigate the roles of acetyltransferases in M. tb, we constructed an acetyltransferase mutant library using CRISPR-assisted genome editing and screened for genes that are essential for mouse infection. Seven acetyltransferases were identified as essential for lung infection of M. tb. cysE, encoding a serine acetyltransferase, was confirmed to be required for virulence of M. tb in mice and its replication in macrophages. Further experiments revealed that mutation of cysE or inhibition of CysE by small molecular chemical increased sensitivity to clofazimine treatment. Finally, we demonstrated that cysE is involved in mitigating oxidative stress, which modulates the virulence and drug resistance of M. tb. Our study suggests that targeting cysE offers potential for the development of anti-tuberculosis drugs, particularly for enhancing treatment regimens for drug-resistant tuberculosis through the synergistic effect with clofazimine.

Indexed as

Drug Resistance, BacterialMycobacterium tuberculosisSerine O-AcetyltransferaseAcetyltransferasesAnimalsAntitubercular AgentsBacterial ProteinsClofazimineFemaleGene Expression Regulation, BacterialMiceMice, Inbred C57BLOxidative StressReactive Oxygen SpeciesSequence Analysis, RNAVirulenceAcetyltransferasesAntitubercular AgentsBacterial ProteinsClofazimineReactive Oxygen SpeciesSerine O-Acetyltransferase

Identifiers

PMID41053365
PMCPMC12500854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.